Determination of the burden of mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after stem cell transplant.
Study #: IN16-02
Study Status: Published
Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant.
Dandoy CE, Kim S, Chen M, Ahn K-W, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales M-A, Lindemans CA, Komanduri KV, Riches ML.
JAMA Network Open. 2020, Jan 03: 3(1): 3(1):e1918668. doi: 10.1001/jamanetworkopen.2019.18668. Epub 2020, Jan 08. PMCID:PMC6991246.
PMID: 31913492
Abstract